Stefan Imobersteg

Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy

S. Frank, M. Grzmil, R. Schibli, 2020, Pharmaceutics.

Onset and offset of aversive events establish distinct memories requiring fear and reward networks.

M. Fendt, P. Pauli, B. Gerber, 2012, Learning & memory.

Signaling Network Response to α-Particle–Targeted Therapy with the 225Ac-Labeled Minigastrin Analog 225Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors

M. Grzmil, R. Schibli, M. Béhé, 2023, The Journal of Nuclear Medicine.

The Gigantocellular Reticular Nucleus Plays a Significant Role in Locomotor Recovery after Incomplete Spinal Cord Injury

M. Schwab, S. Imobersteg, A. Hofer, 2020, The Journal of Neuroscience.

Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [177Lu]Lu-PP-F11N

S. Frank, M. Grzmil, R. Schibli, 2020, Theranostics.

Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [177Lu]Lu-PP-F11N

M. Grzmil, R. Schibli, M. Béhé, 2021, Pharmaceutics.

Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect

M. Fendt, K. Lingenhöhl, S. Imobersteg, 2009, Psychopharmacology.

The positive allosteric modulator GS39783 enhances GABAB receptor‐mediated inhibition of cyclic AMP formation in rat striatum in vivo

S. Urwyler, S. Imobersteg, S. Desrayaud, 2006, Journal of neurochemistry.

Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response

M. Fendt, A. Sailer, S. Imobersteg, 2011, Behavioural Brain Research.

Intra-amygdala injections of neuropeptide S block fear-potentiated startle

M. Fendt, A. Sailer, S. Imobersteg, 2010, Neuroscience Letters.

Brain interstitial fluid glutamine homeostasis is controlled by blood–brain barrier SLC7A5/LAT1 amino acid transporter

E. Laczko, T. Welt, S. Imobersteg, 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

DUAL OREXIN RECEPTOR ANTAGONIST ALMOREXANT INDUCES SLEEP The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors

M. Fendt, D. Hoyer, C. Gee, 2012 .